Changing the way Malignant Melanoma is diagnosed with a new revolutionary screening instrument
| Reference number | |
| Coordinator | Corpus Data & Image Analysis AB |
| Funding from Vinnova | SEK 500 000 |
| Project duration | November 2017 - March 2018 |
| Status | Completed |
Important results from the project
The main goal of the feasibility study performed was to deliver a detailed Business Plan, including a detailed analysis of the feasibility of our project. We have delivered a Business Plan including a feasibility analysis of the project.
Expected long term effects
During a 4 months period we performed the necessary technical, commercial and financial analyses to confirm the viability and profitability of our product. We have found feasibility and have elaborated a 2,5-year plan and budget for the business innovation project leading us to market introduction. Our analysis shows an outstanding economic value of DermaSuspect for Hospitals, Dermatology clinics and Healthcare systems in Sweden (our first key market). More than €11 million saved on direct costs, €5.2 million on biopsy analysis and €42 million on indirect costs.
Approach and implementation
Tasks performed: - Design of final probe prototype combining two spectroscopic methods - Improvement of the analysis software for data acquisition and user interface - Clinical validation of the new probe prototype - Technical risk analysis - Preparation of a detailed technical work plan - Study of market barriers, challenges and competitor’s analysis - Elaboration of dissemination and commercialization strategy - Identification of potential key partners - Update IP strategy and perform a FTO analysis - Validation or profitability and financial projection for 5 years